Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs

Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs

<p>Abstract</p> <p>Background</p> <p>CJ9-gD is a novel dominant-negative recombinant herpes simplex virus type 1 (HSV-1) that is completely replication-defective, cannot establish detectable latent infection <it>in </it>vivo, and expresses high levels of the...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Brans Richard, Yao Feng
Materialtyp:	Artikel
Språk:	English
Publicerad:	BMC 2010-06-01
Serie:	BMC Microbiology
Länkar:	http://www.biomedcentral.com/1471-2180/10/163

Liknande verk

A herpes simplex virus 2 (HSV-2) glycoprotein D-expressing nonreplicating dominant-negative HSV-2 virus vaccine is superior to a gD2 subunit vaccine against HSV-2 genital infection in guinea pigs.
av: Pengwei Zhang, et al.
Publicerad: (2014-01-01)

An Adenovirus-Based Recombinant Herpes Simplex Virus 2 (HSV-2) Therapeutic Vaccine Is Highly Protective against Acute and Recurrent HSV-2 Disease in a Guinea Pig Model
av: Mingming Wan, et al.
Publicerad: (2023-01-01)

Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection
av: Kevin Egan, et al.
Publicerad: (2020-09-01)

Assessment of Two Novel Live-Attenuated Vaccine Candidates for Herpes Simplex Virus 2 (HSV-2) in Guinea Pigs
av: Jonathan D. Joyce, et al.
Publicerad: (2021-03-01)

Virus-specific immune memory at peripheral sites of herpes simplex virus type 2 (HSV-2) infection in guinea pigs.
av: Jingya Xia, et al.
Publicerad: (2014-01-01)

Herpes Simplex Virus Mistyping due to HSV-1 × HSV-2 Interspecies Recombination in Viral Gene Encoding Glycoprotein B
av: Amanda M. Casto, et al.
Publicerad: (2020-08-01)

Herpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine.
av: Joshua J Geltz, et al.
Publicerad: (2015-01-01)

Comparison of the Accuracy of HSV1 and HSV2 Antibody Tests with PCR in the Diagnosis of Recurrent Genital Herpes
av: Deng J, et al.
Publicerad: (2024-08-01)

Reactivation of Herpes Simplex Virus (HSV) from Latency in Response to Neuronal Hyperexcitability
av: Sean Cuddy, et al.
Publicerad: (2020-06-01)

Prevalence of Herpes Simplex Virus Type 1 and 2 (HSV-1 and HSV-2) in the Women with Breast Cancer by Multiplex-PCR method
av: Fatemeh Kaveh, et al.
Publicerad: (2018-05-01)

Enhancement of Herpes Simplex Virus (HSV) Infection by Seminal Plasma and Semen Amyloids Implicates a New Target for the Prevention of HSV Infection
av: Lilith Torres, et al.
Publicerad: (2015-04-01)

Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
av: Marie-Clotilde Bernard, et al.
Publicerad: (2015-01-01)

The population impact of herpes simplex virus type 2 (HSV-2) vaccination on the incidence of HSV-2, HIV and genital ulcer disease in South Africa: a mathematical modelling studyResearch in context
av: Jack Stone, et al.
Publicerad: (2023-04-01)

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment
av: Ifeanyi Kingsley Uche, et al.
Publicerad: (2021-06-01)

Herpes Simplex Virus-type1 (HSV-1) Impairs DNA Repair in Cortical Neurons
av: Giovanna De Chiara, et al.
Publicerad: (2016-10-01)

Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B.
av: McDermott, MR, et al.
Publicerad: (1989)

The Antiviral Potential of Iranian Herbal Pharmacopoeia (IHP) on Herpes Simplex Viruses (HSV): A Review Article
av: Shahin Gavanji
Publicerad: (2022-07-01)

Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV.
av: David M J Houston, et al.
Publicerad: (2017-01-01)

Frequent Recurrences of Genital Herpes Are Associated with Enhanced Systemic HSV-Specific T Cell Response
av: Michal Holub, et al.
Publicerad: (2020-01-01)

Incidental Detection of Hairy Cell Leukaemia with Herpes Simplex Virus (HSV) Related Lip Ulcer Mimicking Carcinoma
av: Pallavi Agrawal, et al.
Publicerad: (2016-08-01)

Host Intrinsic and Innate Intracellular Immunity During Herpes Simplex Virus Type 1 (HSV-1) Infection
av: Thamir Alandijany, et al.
Publicerad: (2019-11-01)

Diagnosis and quantitative detection of HSV DNA in samples from patients with suspected herpes simplex encephalitis
av: Mazyar Ziyaeyan, et al.

Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine in Guinea Pigs
av: Sita Awasthi, et al.
Publicerad: (2023-05-01)

The Topical Novel Formulations of Interferon α-2в Effectively Inhibit HSV-1 Keratitis in the Rabbit Eye Model and HSV-2 Genital Herpes in Mice
av: Anna Ivanina, et al.
Publicerad: (2024-06-01)

Functional Overexpression of Vomeronasal Receptors Using a Herpes Simplex Virus Type 1 (HSV-1)-Derived Amplicon.
av: Benjamin Stein, et al.
Publicerad: (2016-01-01)

The Roles of Host and Viral Antibody Fc Receptors in Herpes Simplex Virus (HSV) and Human Cytomegalovirus (HCMV) Infections and Immunity
av: Jennifer A. Jenks, et al.
Publicerad: (2019-09-01)

Role of IL-4 in an experimental model of encephalitis induced by intracranial inoculation of herpes simplex virus-1 (HSV-1)
av: Márcia Carvalho Vilela, et al.
Publicerad: (2011-04-01)

Reactive oxygen species drive herpes simplex virus (HSV)-1-induced proinflammatory cytokine production by murine microglia
av: Lokensgard James R, et al.
Publicerad: (2011-09-01)

20 years of herpes simplex virus type 2 (HSV-2) research in low-income and middle-income countries: systematic evaluation of progress made in addressing WHO priorities for research in HSV-2/HIV interactions, HSV-2 control and mathematical modelling
av: Angela Obasi, et al.
Publicerad: (2024-07-01)

Effect of genital herpes on cervicovaginal HIV shedding in women co-infected with HIV AND HSV-2 in Tanzania.
av: Jim Todd, et al.
Publicerad: (2013-01-01)

Fast gene transfer into the adult zebrafish brain by herpes simplex virus 1 (HSV-1) and electroporation: methods and optogenetic applications
av: Zou, Ming, et al.
Publicerad: (2014)

Fast gene transfer into the adult zebrafish brain by herpes simplex virus 1 (HSV-1) and electroporation: methods and optogenetic applications
av: Ming eZou, et al.
Publicerad: (2014-05-01)

Occurrence of HSV with other microorganisms in female genital infection
av: Al-Omar S. Layla, et al.
Publicerad: (2005-06-01)

Immunogenicity and Therapeutic Efficacy of a Sendai-Virus-Vectored HSV-2 Vaccine in Mouse and Guinea Pig Models
av: Xiuxiu Ren, et al.
Publicerad: (2023-11-01)

Viral risk factor for seizures: Pathobiology of dynorphin in herpes simplex viral (HSV-1) seizures in an animal model
av: Marylou V. Solbrig, et al.
Publicerad: (2006-09-01)

A Mutation in the Herpes Simplex Virus Type 1 (HSV-1) UL29 Gene is Associated with Anti-Herpesvirus Drugs’ Susceptibility
av: Souichi Yamada, et al.
Publicerad: (2024-11-01)

Analysis of Metagenomic Next-Generation Sequencing (mNGS) in the Diagnosis of Herpes Simplex Virus (HSV) Encephalitis with Normal Cerebrospinal Fluid (CSF)
av: Si Z, et al.
Publicerad: (2023-06-01)

Host Vesicle Fusion Protein VAPB Contributes to the Nuclear Egress Stage of Herpes Simplex Virus Type-1 (HSV-1) Replication
av: Natalia Saiz-Ros, et al.
Publicerad: (2019-02-01)

Visualization of mouse neuronal ganglia infected by Herpes Simplex Virus 1 (HSV-1) using multimodal non-linear optical microscopy.
av: Pierre-Alexandre Rochette, et al.
Publicerad: (2014-01-01)

Enzyme-Assisted Extraction of Bioactive Material from Chondrus crispus and Codium fragile and Its Effect on Herpes simplex Virus (HSV-1)
av: Garima Kulshreshtha, et al.
Publicerad: (2015-01-01)